DE1525541U - - Google Patents

Info

Publication number
DE1525541U
DE1525541U DENDAT1525541D DE1525541DU DE1525541U DE 1525541 U DE1525541 U DE 1525541U DE NDAT1525541 D DENDAT1525541 D DE NDAT1525541D DE 1525541D U DE1525541D U DE 1525541DU DE 1525541 U DE1525541 U DE 1525541U
Authority
DE
Germany
Prior art keywords
iwt
dwr
becomes
bwi
diw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1525541D
Other languages
German (de)
English (en)
Publication of DE1525541U publication Critical patent/DE1525541U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Exhaust Gas After Treatment (AREA)
DENDAT1525541D Active DE1525541U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1525541U true DE1525541U (OSRAM)

Family

ID=826748

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1525541D Active DE1525541U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1525541U (OSRAM)

Similar Documents

Publication Publication Date Title
Kaku et al. Efficacy and safety of fasiglifam (TAK‐875), a G protein‐coupled receptor 40 agonist, in J apanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial
CN100522080C (zh) 外科夹具推进和对准机构
Campbell et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features
Hoenig et al. The nosological position of transsexualism
NO20041941L (no) Doseringsform, utstyr og fremgangsmater for behandling
DE1525541U (OSRAM)
Cao et al. Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials
Mackay et al. Failure of lithium treatment in established tardive dyskinesia
Angulo et al. A phase 2b, dose-selection study evaluating the efficacy and safety of oral ibrexafungerp vs fluconazole in vulvovaginal candidiasis (DOVE)
Walker et al. A multicentre study comparing mazindol and placebo in obese patients
CA2246407A1 (en) Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa
Berger Theileria velifera demonstrated in cattle in the Eastern Cape Province of the Republic of South Africa
ELLIS-PEGLER The effects of World Health Organization chemotherapy on imported leprosy in Auckland, New Zealand, 1983-90
Niang et al. Controlled Trial of 3-Day
Pettigiani The Meaning of the Female Presence in Messianic Texts within the Corpus of the Nevi’im
Knepr The role of public health in emergency situations
Dunn Messene besieged: a note on two (?) engagements in the Peloponnese
Leroy et al. 272-PA12 Survival of HIV-infected patients after tuberculosis, Bordeaux, France, 1988–1994
Nesher et al. Recommendations for drug therapy of rheumatoid arthritis in elderly patients
Wong et al. Proposal to Hamas: 6-Week Pause in Strife and Hostage-Prisoner Swap.
Bruyn Study regimen changes
Thomas et al. Experiments with antimalarial drugs in man: I. The Protective Effect of Proguanil (“Paludrine”) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae
Shabuj et al. Gentamicin in newborn sepsis: Once daily dose versus twice daily dose
Antinori et al. Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS
Kersh et al. P693 Neisseria gonorrhoeae in-vitro susceptibilities to ceftriaxone, cefixime and azithromycin in GISP isolates, 1987–2017